NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our phosphoramidate chemistry technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines.
While these conventional agents remain part of the standard of care for the treatment of many solid tumours, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilising our proprietary ProTide technology, we are developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells.
Location: United Kingdom, Scotland, City of Edinburgh
Member count: 11-50
Total raised: $57M
Founded date: 2008
Investors 3
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | Sofinnova ... | sofinnova.... |
| 22.09.2020 | Abingworth... | abingworth... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 11.04.2014 | Series B | $57M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 24.05.2021 | NUCANA PLC... | NuCana plc Notice of Annual G... | - | - | marketscre... |
| 24.05.2021 | NUCANA PLC... | NuCana plc Notice of Annual G... | - | - | marketscre... |
| 13.09.2020 | Акции, ста... | Активы шести университетских ф... | Финансы... | Olga Bakhl... | vc.ru/fina... |
| 11.04.2014 | NuCana Com... | NuCana, an Edinburgh, UK-based... | funding S... | - | finsmes.co... |
| 29.11.2011 | NuCana Bio... | NuCana BioMed, an Edinburgh UK... | funding U... | - | finsmes.co... |